Cite

HARVARD Citation

    Planchard, D. et al. (n.d.). Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial. Lancet oncology. 17 (5), pp. 642-650. [Online]. 
  
Back to record